<DOC>
	<DOCNO>NCT00385138</DOCNO>
	<brief_summary>The primary objective study demonstrate efficacy cangrelor ( combine usual care ) superior usual care , subject require percutaneous coronary intervention ( PCI ) measure composite all-cause mortality , myocardial infarction ( MI ) , ischemia-driven revascularization ( IDR ) .</brief_summary>
	<brief_title>Cangrelor Versus Standard Therapy Achieve Optimal Management Platelet Inhibition .</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Cangrelor</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Angiography demonstrate atherosclerosis amenable treatment percutaneous coronary intervention ( PCI ) without stent implantation diagnosis Acute Coronary Syndrome ( ACS ) elevate cardiac marker ischemic chest discomfort w/electrocardiogram change + age &gt; 65 diabetes . 1 . Not candidate PCI 2 . STsegment elevation myocardial infarction ( STEMI ) within 48 hour randomization 3 . Increased bleed risk : ischemic stroke within last year previous hemorrhagic stroke , intracranial tumor , cerebral arteriovenous malformation , intracranial aneurysm ; recent ( &lt; 1 month ) trauma major surgery [ include coronary artery bypass graft ( CABG ) surgery ] ; currently receive warfarin , active bleeding 4 . Impaired hemostasis : know International Normalized Ratio ( INR ) &gt; 1.5 screening ; past present bleed disorder ( include congenital bleeding disorder von Willebrand 's disease hemophilia , acquire bleeding disorder , unexplained clinically significant bleed disorder ) , thrombocytopenia ( platelet count &lt; 100,000/ÂµL ) screen 5 . Severe hypertension adequately control antihypertensive therapy time randomization 6 . Receipt fibrinolytic therapy 12 hour precede randomization 7 . Receipt thienopyridine ( clopidogrel ticlopidine ) 7 day precede randomization 8 . Glycoprotein IIb/IIIa ( GPI ) Inhibitor usage within previous 12 hour [ applicable unstable angina ( UA ) nonSTelevation myocardial infarction ( NSTEMI ) patient ]</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Percutaneous Coronary Intervention ( PCI )</keyword>
	<keyword>ACS</keyword>
</DOC>